Abstract
The early Crystal City Bioanalytical workshops did not discuss the requirements for bioanalytical documentation and reports. The major bioanalytical guidance from FDA and EMA provided only broad outlines for the requirements in bioanalytical documentation and reports. The bioanalytical practitioners were therefore left to decide what to document in the reports and what to maintain in the archives for inspection. This has led to bioanalytical reports of various shapes and sizes. Parallel to the development of the bioanalytical guidance, ICH developed an electronic Common Technical Document (eCTD) guidance for preparing regulatory reports. Recently, FDA issued a mandatory guidance for submission of data and reports electronically for certain submissions. These latter changes have also been influencing how the bioanalytical data and reports would be submitted in the future. This chapter provides an overview of the bioanalytical documentation and reports for bioanalytical studies intended for regulatory submission.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shah VP, Midha KK, Dighe SV, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Pharm Res. 1992;9(4):588–92.
Shah VP, Bansal SK. Historical perspective on the development and evolution of bioanalytical guidance and technology. Bioanalysis. 2011;3(8):823–7.
Shah VP, Midha KK, Findlay JW, et al. Bioanalytical method validation—a revisit with a decade of progress. Pharm Res. 2000;17(12):1551–7.
US Department of Health and Human Services, Food and Drug Administration, CDER, CVM, guidance for industry: bioanalytical method validation. 2001. http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf. Accessed 10 May 2016.
Au S, Yu C, Booth B. Utilization of electronic resources in the NDA/BLA regulatory review of bioanalytical data: perspectives from US FDA reviewers. Bioanalysis. 2011;3(13):1441–5.
European Medicines Agency, Committee for Medicinal Products for Human Use. Guideline on validation of bioanalytical methods, [EMEA/CHMP/EWP/192217/2009]. July 2011. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf. Accessed 10 May 2016.
Japan Ministry of Health, Labour and Welfare (MHLW), guideline on bioanalytical method validation in pharmaceutical development. 2013. http://www.nihs.go.jp/drug/BMV/250913_BMV-GL_E.pdf. Accessed 10 May 2016.
Japan Ministry of Health, Labour and Welfare (MHLW), guideline on bioanalytical method (Ligand Binding Assay) validation in pharmaceutical development. 2014. http://www.nihs.go.jp/drug/BMV/260530_LBA-GL_E.pdf. Accessed 10 May 2016.
China State Food and Drug Administration. Technical guideline on clinical pharmacokinetic studies for chemical drugs. China: Beijing; 2005.
Chinese Pharmacopoeia 2015, Guidance on Bioanalytical Method Validation, Vol. 4, pp. 363–8.
Agência Nacional de Vigilância Sanitária (ANVISA), Brazil, Resolution RDC27 (Bioanalytical Guidance). 2012. http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2012/rdc0027_17_05_2012.pdf. Accessed 10 May 2016.
Ministry of Health, Health Products and Food Branch, guidance document: conduct and analysis of comparative bioavailability studies, Canada, 2012. http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/prodpharma/applic-demande/guide-ld/bio/gd_cbs_ebc_ld-eng.pdf. Accessed 10 May 2016.
Bansal SK. International Regulations and Quality Standards of Bioanalysis. In: Li W, Zhang J, Tse FLS, editors. Handbook of LC-MS bioanalysis: best practices, experimental protocols, and regulations. New York: Wiley; 2013.
U.S. Department of Health and Human Services, Food and Drug Administration, guidance for industry: bioanalytical method validation, draft guidance, 2013. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm368107.pdf. Accessed 10 May 2016.
Viswanathan CT, Bansal S, Booth B. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays. Pharm Res. 2007;24(10):1962–73.
Booth B, Arnold, ME DeSilva B, Amaravadi L, Dudal S, Fluhler E, Gorovits B, Haidar SH, Kadavil J, Lowes S, Nicholson R, Rock M, Skelly M, Stevenson L, Subramaniam S, Weiner R, and Woolf E. Workshop report: crystal city V—quantitative bioanalytical method validation and implementation: The 2013 Revised FDA Guidance. AAPS J. 2015;17(2).
Verhaeghe T, Barton HH, Hara H, Hucker R, Kelley M, Picard F, Reddy KS, Salvadori MC, Woolf E. Recommendations from the global bioanalysis consortium team A8: documentation. AAPS J. 2014;16(2).
United States Pharmacopeia, Chapter <1058>, Analytical Instrument Qualification, Rockville, USA.
OECD Good Laboratory Practice: Frequently Asked Questions (FAQ) posted on Jan. 16, 2016. Available at http://www.oecd.org/env/ehs/testing/glp-frequently-asked-questions.htm. Accessed 10 May 2016.
US Department of Health and Human Services, Food and Drug Administration, Providing Regulatory Submissions in Electronic Format—Submissions Under Section 745A(a) of the Federal Food, Drug and Cosmetic Act, Guidance for Industry, FDA. December 2014. http://www.fda.gov/downloads/Drugs/Guidances/UCM384686.pdf. Accessed 10 May 2016.
US Department of Health and Human Services, Food and Drug Administration, Providing rRegulatory Submission in Electronic Format—Standardized Study Data, Guidance for Industry, FDA. December 2014. http://www.fda.gov/downloads/Drugs/Guidances/UCM292334.pdf. Accessed 10 May 2016.
US Department of Health and Human Services, Food and Drug Administration, Study Data Technical Conformance Guide, Technical Specifications Document. 2015. http://www.fda.gov/downloads/ForIndustry/DataStandards/StudyDataStandards/UCM384744.pdf. Accessed 10 May 2016.
US Food and Drug Administration, Data Standards Catalog v4.4 (2015) available in study data standards resources http://www.fda.gov/forindustry/datastandards/studydatastandards/default.htm. Accessed 10 May 2016.
CDISC Submission Data Standards Team, Clinical Data Interchange Standards Consortium, Study Data Tabulation Model (SDTM). http://www.cdisc.org/sdtm. Accessed 10 May 2016.
CDISC Standard for Exchange of Nonclinical Data Team, Clinical Data Interchange Standards Consortium, Standard for Exchange of Nonclinical Data (SEND) implementation guide: nonclinical studies, v. 3.0. 2011. http://www.cdisc.org/send. Accessed 10 May 2016.
The International Council for Harmonisation, M4: the common technical document. http://www.ich.org/products/ctd.html. Accessed 10 May 2016.
The International Council for Harmonisation, The common technical document for the registration of pharmaceuticals for human use: safety—M4S(R2), nonclinical overview and nonclinical summaries of module 2, organization of module 4. 2002. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/CTD/M4__R2__Safety/M4S_R2_.pdf. Accessed 10 May 2016.
The International Council for Harmonisation (ICH), the common technical document for the registration of pharmaceuticals for human use efficacy—M4E(R1), clinical overview and clinical summary of module 2, module 5: clinical study reports, 2002. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/CTD/M4__R1__Efficacy/M4E__R1_.pdf. Accessed 10 May 2016.
US Department of Health and Human Services, Food and Drug Administration, Providing Regulatory Submissions in Electronic Format—certain human pharmaceutical product applications and related submissions using the eCTD specifications, Guidance for Industry. May 2015. http://www.fda.gov/ucm/groups/fdagov-public/@fdagov-drugs-gen/documents/document/ucm333969.pdf. Accessed 10 May 2016.
US Food and Drug Administration, Electronic Common Technical Document (eCTD) website. http://www.fda.gov/Drugs/DevelopmentApprovalProcess/FormsSubmissionRequirements/ElectronicSubmissions/ucm153574.htm. Accessed 10 May 2016.
Acknowledgements
The author would like to thank Jacueline Gillis, Gerard Randolph, and Herbert Birnboeck for their valuable edits and suggestions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Bansal, S.K., Vazvaei, F. (2017). Regulated Bioanalysis: Documentation and Reports. In: Rocci Jr., M., Lowes, S. (eds) Regulated Bioanalysis: Fundamentals and Practice. AAPS Advances in the Pharmaceutical Sciences Series, vol 26. Springer, Cham. https://doi.org/10.1007/978-3-319-54802-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-54802-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54800-5
Online ISBN: 978-3-319-54802-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)